Cargando…

PM498. Investigation of feelings toward taking blonanserin and risperidone in schizophrenia patients: part 2

Detalles Bibliográficos
Autores principales:	Shoji, Yoshihisa, Yanagimoto, Hiroko, Inoue, Masayuki, Ishii, Youhei, Kato, Yusuke, Morita, Kiichiro, Uchimura, Naohisa, Yamashita, Yuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616432/ http://dx.doi.org/10.1093/ijnp/pyw041.498

Ejemplares similares

PM499. Improvement of cognitive function before and after 2-year treatment with long-acting injection (LAI) of antipsychotics evaluated by NIRS using single word-induced hemoglobin variation as an index
por: Shoji, Yoshihisa, et al.
Publicado: (2016)

PS209. Changes of cognitive function after escitalopram administration using single word-induced hemoglobin variation as an index
por: Shoji, Yoshihisa, et al.
Publicado: (2016)

PS179. A depressive patient who achieved remission by escitalopram: cerebral blood flow variation during pleasant/unpleasant image tasks.
por: Shoji, Yoshihisa, et al.
Publicado: (2016)

Comparison of changes in oxygenated hemoglobin during the tree-drawing task between patients with schizophrenia and healthy controls
por: Nakano, Shinya, et al.
Publicado: (2018)

Single event-related changes in cerebral oxygenated hemoglobin using word game in schizophrenia
por: Fujiki, Ryo, et al.
Publicado: (2014)

Reduced prefrontal cortex activation using the Trail Making Test in schizophrenia
por: Fujiki, Ryo, et al.
Publicado: (2013)

Effect of blonanserin on cognitive and social function in acute phase Japanese schizophrenia compared with risperidone
por: Hori, Hikaru, et al.
Publicado: (2014)

PM429. Comparison of haloperidol and blonanserin on development of dopamine supersensitivity after chronic treatment
por: Hashimoto, Takashi, et al.
Publicado: (2016)

PM423. Blonanserin augmentation in patients with schizophrenia – who is benefited from blonanserin augmentation?: An open-label, prospective, multicenter study
por: Woo, Young Sup, et al.
Publicado: (2016)

Efficacy and safety of blonanserin versus risperidone in the treatment of schizophrenia: a systematic review and meta-analysis of randomized controlled trials
por: Deng, Shu-Wen, et al.
Publicado: (2023)

The Changes in Concentration of Cerebral Oxygenated Hemoglobin During Single Event-Related Japanese Shiritori Task in Patients With Major Depression Disorder: Comparison With Healthy Subjects
por: Ishii, Youhei, et al.
Publicado: (2021)

Profile of blonanserin for the treatment of schizophrenia
por: Tenjin, Tomomi, et al.
Publicado: (2013)

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report
por: Sakai, Shintaro, et al.
Publicado: (2021)

Simple and Sensitive Analysis of Blonanserin and Blonanserin C in Human Plasma by Liquid Chromatography Tandem Mass Spectrometry and Its Application
por: Zheng, Yunliang, et al.
Publicado: (2014)

A case of delusional parasitosis responded to blonanserin
por: Rathi, Anubhav, et al.
Publicado: (2018)

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2016)

S220. BLONANSERIN AUGMENTATION IN PATIENTS WITH SCHIZOPHRENIA – WHO IS BENEFITED FROM BLONANSERIN AUGMENTATION? AN OPEN-LABEL, PROSPECTIVE, MULTI-CENTER STUDY
por: Bahk, Won-Myong, et al.
Publicado: (2018)

Blonanserin vs risperidone in Japanese patients with schizophrenia: A post hoc analysis of a phase 3, 8‐week, multicenter, double‐blind, randomized controlled study
por: Harvey, Philip D., et al.
Publicado: (2019)

Early prediction of blonanserin response in Japanese patients with schizophrenia
por: Kishi, Taro, et al.
Publicado: (2014)

Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D(2) Receptor Occupancy: Unique Characteristics of Blonanserin Transdermal Patch
por: Tomita, Yoshiko, et al.
Publicado: (2022)

A Simple and Sensitive HPLC-MS/MS Assay for the Quantitation of Blonanserin and N-Desethyl Blonanserin in Rat Plasma and Its Application to Pharmacokinetic Study
por: Huang, Shan-qing, et al.
Publicado: (2022)

Neurotoxic Syndrome Developed after Taking Sertraline and Risperidone
por: Kim, Jeong-Min, et al.
Publicado: (2007)

PM397. Effectiveness of blonanserin in patients with schizophrenia: A systematic review and meta-analysis of direct head-to-head comparisons with other antipsychotics
por: Kishi, T., et al.
Publicado: (2016)

Fluvoxamine for blonanserin-associated akathisia in patients with schizophrenia: report of five cases
por: Furuse, Tsutomu, et al.
Publicado: (2010)

Blonanserin-induced Mood Alteration in Schizophrenia and Schizoaffective Disorder: Two Cases
por: Min, Aran, et al.
Publicado: (2013)

Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
por: Okazaki, Kosuke, et al.
Publicado: (2016)

"Kegelstatt" Trio, K. 498 Clarinet quartets, K. 317d & K. 496 /
por: Mozart, Wolfgang Amadeus, 1756-1791
Publicado: (1993)

Switching Antipsychotics to Blonanserin in Patients with Schizophrenia: An Open-label, Prospective, Multicenter Study
por: Woo, Young Sup, et al.
Publicado: (2019)

A case of schizophrenia with relapsed catatonia successfully treated with blonanserin transdermal patch
por: Hagikura, Minako, et al.
Publicado: (2023)

PM430. Blonanserin reversed phencyclidine-induced novel object recognition deficit and induced cortical dopamine and acetylcholine efflux through dopamine D(3) receptor antagonism
por: Miyauchi, Masanori, et al.
Publicado: (2016)

PM402. Factors associated with sexual health in Korean patients with schizophrenia receiving risperidone monotherapy
por: Lee, Ju-Yeon, et al.
Publicado: (2016)

A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
por: Kishi, Taro, et al.
Publicado: (2016)

Survival of Combined Overdose with Very High Doses of Clozapine and Blonanserin: A Case Report
por: Faisal, Mohammad, et al.
Publicado: (2022)

SUN-498 A Case of Thyroid Storm with Systemic Thromboembolism
por: Maung, Aye Chan, et al.
Publicado: (2020)

SAT-498 Graves’-Associated Takotsubo Cardiomyopathy: An Uncommon Condition
por: Mortensen, Michael, et al.
Publicado: (2020)

Possible effect of blonanserin on gambling disorder: A clinical study protocol and a case report
por: Shiina, Akihiro, et al.
Publicado: (2021)

Long-term oral blonanserin treatment for schizophrenia: a review of Japanese long-term studies
por: Murasaki, Mitsukuni, et al.
Publicado: (2021)

498 Mastocytosis and IgE-dependent Sensitization: Report of 2 Cases
por: Toche, Paola, et al.
Publicado: (2012)

MON-498 When to Sweat the Details: A Case of Adult Hypophosphatasia
por: Behari, Gauri, et al.
Publicado: (2019)

SUN-498 Normocalcemic Tetany: Is Parathyroid Insufficiency a Real Thing?
por: Chhetri, Mamta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ti0o6j3uktal4dfaaf7epn3s75